SCIESCOPUSQ3
International Journal of Rheumatic Diseases
WILEY, United States
International Journal of Rheumatic Diseases is an academic journal published by WILEY (United States). Identifiers: ISSN 1756-1841, eISSN 1756-185X. Indexed in SCIE, SCOPUS. Metrics: JIF 2.0, CiteScore 3.5, SJR 0.582, SNIP 0.68. Subject areas: RHEUMATOLOGY. tlooto lists 4,833 papers from this journal.
CiteScore
3.50
Scopus citation metric
SJR
0.582
SCImago rank
SNIP
0.68
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 1756-1841
- eISSN
- 1756-185X
- Abbreviation
- INT J RHEUM DIS
- Publisher
- WILEY
- Country
- United States
Web of Science categories
SCIERHEUMATOLOGY
Scopus ASJC categories
2745 Rheumatology
Keywords
Rheumatology
Papers in this journal
Recent papers
- Current and Future Challenges of Hypogammaglobulinemia in Autoimmune Rheumatic Disease Patients Receiving B‐Cell Therapies
2026
- Association Between the Fatigue Assessment Scale and Clinical Indices in Patients With Systemic Lupus Erythematosus
2026
- Identifying Antigen-Specific Autoreactive B Cells in Sjögren's Disease: Methodological Challenges and Emerging Strategies.
2026
- Global Pattern, Trend, and Cross-Country Inequality of Low Bone Mineral Density From 1990 to 2021: Findings From the Global Burden of Disease Study.
2026
- Certolizumab Pegol Reduced Anterior Uveitis Flares Compared With Standard Non‐Biologic Treatment: Results From an Overlap Weighting Analysis in High‐Risk Patients With Axial Spondyloarthritis
2026
Most cited papers
- Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients
2011 · 404 citations
- The epidemiology of osteoarthritis in Asia
2011 · 394 citations
- Two new inflammatory markers associated with Disease Activity Score‐28 in patients with rheumatoid arthritis: neutrophil‐lymphocyte ratio and platelet‐lymphocyte ratio
2015 · 219 citations
- Rituximab in intractable ocular lesions of Behcet’s disease; randomized single‐blind control study (pilot study)
2010 · 217 citations
- Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double‐blind clinical trial
2014 · 209 citations